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Abstract
Knee ultrasound is a very useful tool for the clinical examination of rheumatic patients. In the last years many papers 
have been focused on this subject, exhibiting a high degree of improvement since the first musculoskeletal ultrasound paper 
concerning the knee was published 30 years ago. Apart from the accurate description of anatomic landmarks and structures 
and also of the basic pathological findings (fluid, synovitis, enthesitis, osteophytes), rheumatologic research has focused on 
inflammatory findings quantification and their reaction to remissive treatments. The aim of this review is to describe the nor-
mal ultrasonographic appearance of knee structures concisely and mainly to analyse the literature about pathological findings 
in the knee joint.
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Introduction
Although the knee is widely considered to be the 
most accessible joint for clinical examination, knee ul-
trasound (US) was proven to be superior in both accu-
racy and reproducibility when compared to the clinical 
exam [1]. 
Being a relatively deep joint, the use of low freqwency 
probes is recommended for knee US. The first published 
US image of a human joint referred to the knee, specifi-
cally to differentiate Baker’s cyst from thrombophlebitis, 
and was performed in 1972 [2]. Since then, many papers 
have focused on this subject and discovered elements of 
anatomy and main pathology of the knee. 
The aim of this review is to analyse the recent lit-
erature on this subject, focusing first on a brief descrip-
tion of the knee anatomy, and then on the most relevant 
pathologic aspects of rheumatic disease. 
US scanning technique
Standardized scanning of the knee is performed with 
a linear 5-13 MHz transducer, except for the most super-
ficial structures that might need a 15 MHz probe [3]. The 
patient’s position depends on the area depicted: dorsal 
decubitus with a slight knee flexion for the anterior side 
and ventral decubitus with extended knee for posterior 
side.
US anatomy
For didactic reasons, the knee will be divided in four 
compartments: anterior, medial, lateral, and posterior. 
The main anatomic structures from these compartments 
are summarized in tables I and II together with the trans-
ducer position in order to maximize their visualization 
(table I) and the ultrasonographic correspondent image 
(table II).  US assessments are more helpful if the ex-
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aminations are dynamic, covering most of the region of 
interest, and if depicted structures (muscles, tendons, 
ligaments, nerves, cartilage, menisci, and cortical bone) 
are visualized in their entire length. Moreover, since pan-
oramic views are available on most of the recently used 
US machines, it is now possible to depict in one image 
the whole length of a structure, regardless of its dimen-
sions. US representative images of anterior and medial 
compartments are visualised in figures 1-3.
Table I. Main anatomic structures and related ultrasonographic 
scans
Com-
part-
ment
Structure Transducer position
Anterior Quadriceps tendon (Qt) Longitudinal scan
Patellar tendon (Pt) Longitudinal scan
Suprapatellar recess (S) Longitudinal scan
Prefemoral fatpad (Pf) Longitudinal scan
Suprapatellar fatpad ( Sf) Longitudinal scan
Patella (P) Longitudinal scan
Tibial tuberosity (Tt) Longitudinal scan
Cartilage ( C) Transverse scan
Medial Tibiofemoral medial joint Longitudinal scan
Medial meniscus (Mm) Longitudinal scan
Medial collateral ligament (MCL) Longitudinal scan
Semimembranosus insertion(Sm) Transverse scan 
Pes anserine insertion(Pa) Longitudinal scan
Lateral Lateral tibiofemoral joint space Longitudinal scan
Lateral meniscus (Lm) Longitudinal scan
Lateral collateral ligament(LCL) Longitudinal scan
Iliotibial band(Itb) Longitudinal scan
Popliteus tendon(PoT) Transverse scan
Biceps femoris insertion Longitudinal scan
Peroneal nerve Transverse scan
Posterior Posterior horns of menisci Longitudinal scan
Femoral condyles cartilage Longitudinal scan
Gastrocnemius muscle(GM) Transverse scan
Gastrocnemius tendon(Gt) Transverse scan
Semimembranosus tendon(Sm) Transverse scan
Popliteal artery and veins(PV) Transverse scan
Fig 1. Ultrasound of the knee in a healthy individual. 
Longitudinal anterior scan at the suprapatellar recess 
level. Normal quadriceps tendon (↑) and normal amount 
of synovial fluid (*) are visualized. F: femur; P: patella
Fig 2. Ultrasound of the knee in a healthy individ-
ual. Transverse suprapatellar scan. Normal hyaline 
cartilage of the femoral condyles (o) is visualized. 
Fig 3. Ultrasound of the knee in a healthy individual. 
Longitudinal scan of the medial aspect of the joint. 
Normal medial collateral ligament (↑) and normal in-
ternal meniscus   (*) are visualized. F: femur; T: tibia
US pathology
1. Joint effusion and synovial hypertrophy
An amount of fluid of more than 3 ml can be depict-
ed in the knee joint with US [3] (fig 4). Three recesses 
of knee synovia are visualized by US on the anterior 
part of the knee: suprapatellar, parapatellar lateral, 
and parapatellar medial. As fluid is displaceable, care 
should be taken to avoid pressure with the probe. The 
320 Violeta Vlad et al Ultrasound of the knee in rheumatology
usual knee fluid assessment starts with the suprapatel-
lar recess, and continues with the lateral and medial re-
cesses, as they are the most dependent when the patient 
is in dorsal decubitus. After effusion detecting, com-
pression with the transducer is recommended, in order 
to differentiate between fluid and synovial hypertrophy 
(fig 5), which is not displaceable. The development of 
Power Doppler US (PDUS) technique has lead to im-
proving information regarding the local activity, know-
ing that PDUS detects inflamed tissues hyperemia. The 
knee is a relatively deep joint, so PDUS signal isl not 
always present in case of synovitis. However, its pres-
ence is indicative of active inflammation. 
The superiority of US examination over clinical exam 
in the swollen knee was proven first by Hauzeur et al 
[1], and a few years later by Kane et al regarding Rheu-
matoid Arthritis (RA) fluid in the knee [4]. This applies 
for suprapatellar recess, parapatellar lateral and medial, 
Table II. Main anatomic structures depicted by ultrasound and related sonographic pattern
Com-
part-
ment
Structure Ultrasonographic aspect
Anterior Quadriceps tendon (Qt) Fibrillar hypoechoic structure inserting on superior pole of the patella
Patellar tendon (Pt) Fibrillar hypoechoic structure inserting on inferior pole of the patella and on tibial tuberosity
Suprapatellar recess (S) Hypo/anechoic line between prefemoral and suprapatellar fatpad
Prefemoral fatpad (Pf) Hyperechoic structure on top of femoral cortex
Suprapatellar fatpad ( Sf) Hyperechoic structure under quadriceps tendon insertion
Patella (P) Hyperechoic line
Tibial tuberosity (Tt) Hyperechoic line
Cartilage ( C) Anechoic band parallel to trochlea, knee in hyperextension
Medial Tibiofemoral medial joint Two bony heads ( hyperechoic) coming together
Medial meniscus (Mm) Hyperechoic triangle inside the joint
Medial collateral ligament (MCL) Fibrillar hyperechoic structure from medial epycondyle to anteromedial tibia
Semimembranosus insertion(Sm) Hyperechoic ovoid in a sulcus near medial meniscus
Pes anserine insertion(Pa) Hyperechoic structure inserting together with MCL, on top of it
Lateral Lateral tibiofemoral joint space Two bony heads coming together
Lateral meniscus (Lm) Hyperechoic triangle inside the joint
Lateral collateral ligament(LCL) Hypoechoic structure over the joint space with sinuous traject
Iliotibial band(Itb) Hyperechoic structure inserting on Gerdy’s tubercle on tibia
Popliteus tendon(PoT) Hyperechoic ovoid in a sulcus next to lateral meniscus
Biceps femoris insertion Hyperechoic structure inserting on fibular head, on top of LCL
Peroneal nerve Hyperechoic ovoid with dots inside near fibular head
Posterior Posterior horns of menisci Hyperechoic triangles on lateral and medial joint spaces 
Femoral condyles cartilage Anechoic band parallel to bony cortex
Gastrocnemius muscle(GM) Hypoechoic pennate structure
Gastrocnemius tendon(Gt) Hyperechoic triangle on top of gastrocnemius muscle
Semimembranosus tendon(Sm) Hyperechoic ovoid next to gastrocnemius
Popliteal artery and veins(PV) Anechoic ovoids with Doppler signal inside, veins compressible
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and Baker cysts. On the other hand, clinical exam proved 
itself to underestimate knee inflammation. 
Effusion is defined by OMERACT as an abnormal 
hypoechoic or anechoic intraarticular material that is 
compressible and displaceable and does not exhibit Dop-
pler signal. Synovial hyperthropy is defined as an ab-
normal hypoechoic intra-articular tissue that is nondis-
placeable and poorly compressible and may exhibit the 
Doppler signal [5]. The dimensions can be evaluated by 
the direct measurement of knee effusion at its greatest 
point of thickness inside the suprapatellar recess [6], and 
in that case a >3mm diameter of suprapatellar recess is 
considered pathologic [7]. 
The presence of the PDUS signal inside the knee joint 
can be used to differentiate between hypervascular and 
fibrous pannus, but it might not always be accurately vis-
ualized, mainly because of the deep location of the joint. 
Fiocco et al proved that by using contrast enhanced Dop-
pler (CED), the method has enhanced reliability, consist-
ently reducing artefacts, when comparing to arthroscopy 
as the gold standard [8]. However, the use of contrast 
agents can be considered time consuming and therefore 
cannot be used in daily practice. 
Knee synovitis in RA is sometimes refractory (per-
sistent for more than 6 months of aggressive local and 
systemic treatment) or relapsing during the treatment, 
and that may cause great damage to the joint, leading fre-
quently to arthroplasty. This is another important reason 
for the indication of repeated examinations of the knee 
joint by US especially in RA. As quantification of dis-
ease activity in RA is an important issue nowadays for 
starting or monitoring biologic treatment, US became 
very important together with clinical scores for global 
evaluation. More than 10 different US scores were de-
fined in the last years, including different joints, mostly 
hand joints. The knee was also included in some of these 
scores [9-11]. The possibility of developing US scores 
emerged from the description of the semiquantitative 
scale as a quantifying method with high reproducibility 
[12]. US scores are based on adding the values of semi-
quantitative grades in specific joints (from a scale 0-3). 
This modality of quantification being relatively easy, can 
be applied to large joints as knee as well. 
US is frequently used to evaluate the therapeutic in-
tervention in the RA knee. Fiocco et al tested the spe-
cific action of Etanercept on RA and Psoriatic arthritis 
patient’s knees, in patients with persistent knee synovitis 
after methotrexate and other DMARDs. The conclusion 
was that Etanercept can suppress persistent knee synovi-
tis in most patients [13]. Regarding PDUS, the study re-
ported the decrease in vascularization first in the superfi-
cial layer of knee pannus, and later in the deeper one. The 
separation between the two layers of inflammation inside 
knee synovitis was reanalysed by Kasukawa et al [14]. 
Superficial flow signals were defined as located in the su-
perficial half of the pannus and fluid space whereas deep 
flow signals were located in the deep half of the pannus. 
Joints with superficial pattern had a higher flow signal 
and a higher synovial effusion grade, whereas joints with 
deep pattern had a higher grade of synovial proliferation. 
In a systematic review focusing on the responsive-
ness of knee arthritis to therapy, Keen et al [15] reviewed 
the studies in which US synovitis of the knee was as-
sessed (Gray Scale and PD) before and after a therapeutic 
intervention. The authors defined internal responsiveness 
as the ability of an outcome tool to demonstrate temporal 
changes in response to therapy and external responsive-
ness as the extent to which changes in an outcome tool 
correlate with other referenced measures [15]. US of the 
knee demonstrated internal responsiveness with regard to 
synovial thickness, effusion size and popliteal cyst size 
Fig 4. Ultrasound of the knee. Longitudinal anterior 
scan of the suprapatellar recess showing the pres-
ence of enthesophytes at the quadriceps tendon’s 
enthesis (↑) and mild effusion (*). F: femur; P: pa-
tella
Fig 5. Ultrasound of the knee. Longitudinal anterior 
scan of the suprapatellar recess showing the pres-
ence of mild effusion (*) and mild synovial hyper-
trophy (o). F: femur; P: patella
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in 3 studies, while other 4 studies found correlations be-
tween US and subjective measurements of health status 
[15]. Unfortunately, the authors found a great heteroge-
neity of working methods in knee US examintaion, lead-
ing to the conclusion that US still needs a great work for 
standardization.
In a pilot study on 104 knees, Vlad et al revealed that 
effusion dimensions measured in RA knees are strongly 
correlated to the pain expressed by the patient quantified 
using the VAS score in the same day as the US examina-
tion in a blind manner [16].
Trying to study the prevalence of US pathologic ab-
normalities encountered in RA knees, Riente et al discov-
ered effusion in 70% of the 200 knees; 82% of these had 
synovial hypertrophy accompanying the effusion, with 
only 19%  a PD positive signal [17]. In a psoriatic arthri-
tis group comprising 186 knees, Delle Sedie et al discov-
ered in 84.3% of joints at least one sign of inflammation 
(effusion and/or synovial hypertrophy) [18].
Regarding knee osteoarthritis, a report of the EULAR 
on US use in this pathology discovered in 600 patients 
examined, 53.7% with no signs of inflammation (effu-
sion or synovitis), 29.5% with joint effusion alone, 14.2% 
with both synovitis and effusion, and 2.7% with synovitis 
alone [19,20]. Inflammation found by US correlated well 
to advanced radiographic disease on the Kellgren-Law-
rence scale, but not to pain intensity during recent physi-
cal activity. The explanation could be linked to the pain 
source in osteoarthritis, which may be especially linked 
to bone oedema, seen only on MRI. However, the pres-
ence of inflammatory signs on US suggests an inflamma-
tory pathway for osteoarthritis, too. 
Proofs regarding inflammation in osteoarthritis are 
increasing; in a recent study, Clockaerts et al showed cy-
tokine production by infrapatellar fatpad [21]. It is still 
unclear how inflammation can affect the natural evolu-
tion of osteoarthritis. Chao et al [22] examined clinically 
and by US 79 patients with symptomatic knee osteoar-
thritis, and then infiltrated their knees with corticoster-
oids/placebo after randomization. The conclusion was 
that corticosteroids have a short time effect on knee pain 
compared to placebo. They also defined the concept of 
US inflammatory signs in osteoarthritis by the presence 
of intraarticular synovial hypertrophy with or without 
effusion. „Inflammatory patients” were called patients 
with knee effusion and they were proven to experience 
a shorter benefit from steroids injection than the patients 
with a dry knee joint. In conclusion, lack of synovitis on 
US may be a good prognostic sign, showing that symp-
toms might be easily controlled by intraarticular steroids. 
This was the first study to prove the ability of US exam to 
predict response to a treatment. 
2. Baker’s cyst and other knee bursitis
Popliteal cysts were first described by Adams in 1840, 
but Baker in 1877 established the causality relation with 
joint effusions and offered the definition [23]. Gastrocne-
mius and semimebranosus bursitis is called Baker cyst. 
It communicates with the joint through the bursal’s neck 
– the joint fluid accumulates in the bursa in knee flexion 
and cannot go back due to the one-way valve mechanism 
[3].  Sometimes, Baker cysts may be giant and ruptured 
into the calf, causing inflammation resembling throm-
bophlebitis. The differential diagnosis between these two 
entities can be easily done by US examination. Any dis-
ease causing fluid accumulation inside the knee can lead 
to a Baker cyst formation. 
The general prevalence of Baker cysts in population 
is evaluated with  many variations. In a study compar-
ing MRI with US in the detection of Baker’s cysts, US 
detected 100% of the MR detected cysts [24]. The inci-
dence of Baker’s cysts in a group of 99 consecutive pa-
tients with RA was 33.8% [ 25]. In a group of 100 patients 
programmed to knee arthroscopy for various reasons the 
incidence of Baker’s cyst was 20% [26]; in a study by 
Ward et al, out of 36 evaluated pathological knees, 58% 
had Baker’s cysts [24]. Although the incidence is not 
clearly established yet, the popliteal fossa must be exam-
ined every time when knee US is performed, especially 
when fluid is found in the anterior recesses. 
The content of a cyst may be variable depending on 
the base pathology- cysts may contain fluid (anechoic im-
age), synovial hypertrophy (hypoechoic images inside, 
sometimes with cauliflower aspect resembling knee syn-
ovitis), calcifications, osteochondral fragments. If Baker 
cysts develop slowly, the patient may be asymptomatic.
Baker cysts were proven to regress following remis-
sive treatment in RA together with knee synovitis [24-
26].
Other knee bursitis are prepatellar and infrapatellar 
bursitis. Prepatellar bursitis is superficially located, and 
it is mainly posttraumatic. Infrapatellar bursitis is super-
ficial (in continuation with prepatellar bursitis, over the 
last third of the patellar tendon), or deep (between the 
patellar tendon and Hoffa’s fatpad). Deep infrapatellar 
bursitis can accompany tendon and entheseal pathology 
of that area. An important aspect to mention is that while 
no fluid is normally found in prepatellar bursitis, a small 
amount in deep infrapatellar bursa is common in healthy 
subjects [3].
3. Tendon and entheseal pathology
The most encountered knee tendon pathology in 
rheumatology is the inflammation of their bony insertion 
known as enthesitis, widely considered as the hallmark 
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for spondylarthropathies (SpA). It is also known that en-
thesitis may affect primarily lower limbs, knee together 
with the heel being the most frequently affected joints.  
US definition of enthesopathy includes an abnormally 
hypoechoic and/or thickened tendon at its bony attach-
ment, occasionally with calcifications, seen in two per-
pendicular planes that may exhibit a Doppler signal, and 
also bony changes – entesophytes, erosions or irregulari-
ties [5] (fig 4). The inflammatory enthesopathy is known 
as enthesitis and it has been widely studied with US, 
mostly since biologic treatment emerged in SpA and had 
to be objectively monitored. 
The quadriceps tendon insertion and the patellar ten-
don/ligament both insertions, as well as suprapatellar and 
infrapatellar bursitis were included in the GUESS score, 
one of the first available US scores to quantify enthesitis 
[27]. The study found numerous subclinical enthesitis in 
SpA and proved US to be more sensitive and more spe-
cific than clinical examination. GUESS score, consisting 
only in Gray Scale examinations, was proven reproduc-
ible for treatment evaluation of SpA patients, but values 
obtained did not correlate to systemic parameters of dis-
ease activity, like in RA.
Adding PDUS to knee enthesitis evaluation, 
D’Agostino et al found abnormal vascularization in 81% 
out of 164 consecutive SpA patients; in the knee, quadri-
ceps tendon was less affected than patellar tendon [29]. 
An important conclusion of the study was that US shows 
enthesitis signs ( PDUS) mostly in SpA patients with pe-
ripheral form of disease – psoriatic arthritis and reactive 
arthritis [28,29].
Regarding enthesitis response to treatment, Naredo et 
al investigated a group of 327 patients with SpA before 
and after anti-TNF alfa treatment. They concluded that 
enthesis morphologic abnormalities, PD signal and bur-
sitis are active inflammatory lesions responsive to bio-
logic therapy, and calcifications and bone lesions are not 
responsive, being them as structural damage lesions [30]. 
The same three enthesis points were included from the 
knee. Together with enthesitis, the presence of synovial 
effusion was also considered as inflammatory, being re-
versible to treatment. 
Enthesitis of the quadriceps tendon was found also in 
RA patients [31], less common than in psoriatic patients, 
and always accompanied by effusion. Also, inflamma-
tory signs previously described appear more often in RA 
whereas in psoriatic arthritis patients exhibit more struc-
tural damage. 
4. Bone and cartilage abnormalities
Knee osteoarthritis is one of the most encountered 
diseases among general population, with a women pre-
dilection. The most specific US sign for osteoarthritis are 
the osteophytes, defined as step-up bony prominence at 
the end of the normal bony contour or at the margin of 
the joint seen in two perpendicular planes, with or with-
out acoustic shadow [27] (fig 6). In the knee joint, the 
place to look for osteophytes is the tibiofemoral joint.  In 
advanced disease, osteophytes can permanently compro-
mise the joint structures (capsule, menisci or ligaments), 
leading to secondary pathology (ligament rupture, menis-
cal clefts or meniscal cysts). The indication for US is in 
the early stage of the disease, mainly for diagnosis.
Cartilage at the knee joint has a thickness of about 
3mm [27] (fig 2). Signs of deterioration appear on US as 
blurring, loss of sharp contour, and margin irregularities. 
Usually in osteoarthritis the cartilage is asymmetrically 
thinned, being more symmetrically affected in RA. Knee 
cartilage is best visualized at the patellar level, with hy-
perflexed knee, and also from the posterior view, along 
femoral condyles. 
US was recently proven to be very accurate in car-
tilage depiction of knee condylar cartilage in cadaver 
specimen [32].
5. Knee joint injection
Intraarticular joint injections of the knee are per-
formed frequently in rheumatologic daily practice. The 
placement of the needle must be strictly inside the joint, 
no matter if the maneuver is for aspirating fluid or for 
therapeutic agents injection (corticosteroids or viscosup-
plementation substances). Only 56-85% of intraarticular 
(IA) injections are correctly placed [33,34], without using 
an imaging modality to guide the needle. Other studies 
demonstrate a higher rate for non guided IA knee injec-
tion – up to 93% [35-37]. Sonographic needle guidance 
has been proven to enhance clinical outcomes (pain con-
trol) and cost-effectiveness of the procedure [36].  Balint 
et al reported a 4/10 rate of success in a blinded aspira-
tion of the knee, compared to 18/19 when using US [37]. 
Fig 6. Ultrasound of the knee. Longitudinal scan of 
the medial aspect of the joint showing the presence 
of an osteophyte (↑). Normal internal meniscus (*) 
is also visualized. F: femur; T: tibia
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In a systematic review, Hermans et al [38] included nine 
studies on the matter of needle placement inside knee joint. 
The most accurate (and the most used) approach of the knee 
is the superolateral one, with the knee in extension, resulting 
in a 91% pooled accuracy. Other approaches are lateral mid-
patellar, anterolateral and anteromedial approach, which 
showed a lower accuracy. A medial patellar approach was 
used by Sang Hee et al to guide intraarticular hyaluronan in 
a dry knee- the guided injections had an accuracy of 95,6% 
compared to 77.3% in blinded injections [39].
The main agents used for knee IA injections are cor-
ticosteroids, both in refractory synovitis in inflammatory 
conditions (RA, SpA, PsA) and for symptomatic relief in 
OA. IA corticosteroids are recommended by ACR guide-
lines of knee RA/ OA treatment since 2002/2000 [40,41].
US guided knee injection is able to improve the ac-
curacy from 82% in a blinded manner to 91%, even if 
the rheumatologist was a young doctor with basic US 
training in the Cunnington et al study [42]. The minimal 
difference between the two types of procedure was only 
obtained for the knee, suggesting that for the other joints 
the need for US guidance is higher. 
The use of viscosupplementation for knee OA is also 
comprised in ACR guidelines for treatment [40]. Hy-
aluronan treatment is mostly indicated in painful knee 
OA with no or mild effusion [43]. US highly improves IA 
needle placement in such conditions, and its importance 
is augmented by the fact that the periarticular hyaluronic 
acid injection showed no improvement in knee pain.
Conclusion
US of the knee is a very frequently encountered proce-
dure, both for clinical practice and for research purposes. 
Knee US, should be performed in all patients with RA as well 
as in OA, US evaluation of the knee enhances the possibility 
of detecting and extracting fluid. Recognizing the presence of 
knee effusion is not always easy at clinical examination. With 
US, even a beginner can obtain very good results in detecting 
knee effusion. In a recent study, 21 medical students were 
able to detect knee injected fluid on cadavers, after a few 
hours of teaching [44]. This is a strong reason for introducing 
US in rheumatology teaching process at all levels.
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